Shintaro Fukushima

发表

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

K. Ichimura, S. Fukushima, N. Kawahara, 2013, Acta Neuropathologica.

Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation

H. Tsuda, S. Fukushima, A. Maeshima, 2013, Brain Tumor Pathology.

Low tumor cell content predicts favorable prognosis in germinoma patients

K. Sugiyama, Hideo Nakamura, T. Maehara, 2021, Neuro-oncology advances.

Integrated Clinical, Histopathological, and Molecular Data Analysis of 190 Central Nervous System Germ Cell Tumors from the iGCT Consortium.

H. Nakase, K. Sugiyama, Hideo Nakamura, 2019, Neuro-oncology.

Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas

K. Sugiyama, Y. Totoki, Hiromi Nakamura, 2017, Acta Neuropathologica.

Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy

K. Sugiyama, T. Maehara, Y. Totoki, 2016, Acta Neuropathologica.

Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas

A. Otsuka, T. Shibata, K. Ichimura, 2014, Acta Neuropathologica.

Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cells.

M. Shigemori, S. Fukushima, S. Kato, 2008, International journal of oncology.

Revisiting TP53 Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse Gliomas

K. Ichimura, S. Fukushima, H. Arita, 2015, Brain pathology.

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas

T. Maehara, T. Ushijima, K. Ichimura, 2016, Neuropathology and applied neurobiology.

Primary choroid plexus T-cell lymphoma and multiple aneurysms in the CNS

M. Hirohata, M. Shigemori, S. Fukushima, 2006, Leukemia & lymphoma.

Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors

K. Sugiyama, T. Maehara, M. Nagane, 2015, Journal of Neuro-Oncology.

IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy.

Minako Sumi, Yoshiko Okita, Yoshitaka Narita, 2012, International journal of oncology.

Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status

K. Ichimura, S. Fukushima, T. Kayama, 2012, Brain Tumor Pathology.

Multinodular and vacuolating neuronal tumor of the cerebrum

K. Ichimura, S. Fukushima, H. Arita, 2015, Brain Tumor Pathology.

Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.

K. Ichimura, S. Fukushima, H. Arita, 2016, Japanese journal of clinical oncology.

Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas

K. Ichimura, S. Fukushima, H. Arita, 2014, Brain Tumor Pathology.

Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas

K. Ichimura, S. Fukushima, H. Arita, 2017, Brain Tumor Pathology.

Clinical presentation of anaplastic large-cell lymphoma in the central nervous system

T. Maruyama, Y. Muragaki, S. Fukushima, 2013, Molecular and clinical oncology.

GERM CELL TUMOURS

Dong Seok Kim, Teo Wan Yee, R. Gibbs, 2014, The Ulster Medical Journal.

Cell density-dependent regulation of tumor necrosis factor alpha gene expression in a human hepatoma cell line.

K. Koike, S. Fukushima, N. Kaneko, 2007, International journal of oncology.

Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma

T. Maehara, H. Mano, M. Nagane, 2017, Acta Neuropathologica.

Clincopathological analysis of olfactory neuroblastoma

K. Ohshima, S. Fukushima, D. Niino, 2012, Brain Tumor Pathology.

Granulocytic sarcoma: an unusual complication of acute promyelocytic leukemia causing cerebellar hemorrhage. Case report.

M. Shigemori, Y. Tajima, Mizuhiko Terasaki, 2006, Journal of neurosurgery.

CELL BIOLOGY AND SIGNALING

V. P. Collins, Michael A. Koldobskiy, R. Spang, 2010 .

Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.

M. Shigemori, S. Fukushima, E. Bouffet, 2008, Surgical neurology.

Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial.

M. Shigemori, S. Fukushima, K. Sakata, 2007, Surgical neurology.

IDH 1 / 2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

K. Ichimura, S. Fukushima, T. Kayama, 2012 .

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases

Seiya Kato, Yasuo Sugita, Shintaro Fukushima, 2009, Brain Tumor Pathology.

Short communication: sclerosing meningioma in the deep sylvian fissure

K. Ichimura, S. Fukushima, H. Arita, 2014, Brain Tumor Pathology.

A SHORT TEXTBOOK OF MEDICINE

Dong Seok Kim, Teo Wan Yee, R. Gibbs, 1973, The Ulster Medical Journal.

Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas

K. Ichimura, S. Fukushima, Y. Matsushita, 2013, Brain Tumor Pathology.

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas

K. Ichimura, S. Fukushima, H. Arita, 2013, Acta Neuropathologica.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors

Naoki Kagawa, Akihiko Yoshida, Shuichi Izumoto, 2018, Acta Neuropathologica Communications.